VJRegenMed is committed to improving our service to you

Share this video  

VJRegenMed is committed to improving our service to you

EBMT 2020 | European regulation and access to advanced therapies

Aurélie Mahalatchimy • 1 Sep 2020
EBMT 2020
General
Communication Perspectives Policy

Aurélie Mahalatchimy, PhD, Aix-en-Provence, Provence-Alpes-Côte d’Azur, France, discusses European law on the regulation and access to advanced therapies. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).

More from Aurélie Mahalatchimy

5:43
Gene editing: legal and ethical considerations
Aurélie Mahalatchimy • 1 Sep 2020
2:19
European regulation of advanced therapies
Aurélie Mahalatchimy • 1 Sep 2020

Related Videos

0:55
Multivalent gamma-delta T-cells: promising agents for the treatment of cancers
Jürgen Kuball • 10 Feb 2023
1:26
Rapid CAR-T manufacturing and challenges in this space
Nina Worel • 9 Feb 2023
1:13
An insight into novel third-generation TLR2 co-stimulatory CAR-T cells
Yasmin Nouri • 9 Feb 2023
3:00
Addressing challenges in using MSCs in cell therapies
Ross Macdonald • 19 Apr 2022
The content of VJRegenMed is intended for healthcare professionals